Mcf Advisors LLC Penumbra Inc Transaction History

Mcf Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$172.27 - $223.95 $1,205 - $1,567	-7 Reduced 29.17%	17 $3,000
Q4 2023 Feb 01, 2024	SELL	$181.44 - $260.22 $3,991 - $5,724	-22 Reduced 47.83%	24 $6,000
Q3 2023 Oct 19, 2023	BUY	$240.69 - $338.77 $2,647 - $3,726	11 Added 31.43%	46 $11,000
Q4 2022 Jan 31, 2023	BUY	$151.88 - $228.5 $5,315 - $7,997	35 New	35 $7,000

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mcf Advisors LLC with notifications on news.